Tadalafil (Cialis 20mg) PharmaQO 50
$95.00
tadalafil pill the Qty is 50 at 20mg each.
- Research grade
- USA made
- 20mg
- Tadalafil (Cialis 20mg) PharmaQO 50
1 in stock
- Certificate of analysis available per batch
- Ships from a US facility
- Free shipping on orders over $175
- COA available Certificate of analysis per batch
- USA made Third-party verified
- Same-day dispatch On orders placed before cut-off
- Free shipping over $175 Applied automatically at checkout
About Tadalafil (Cialis 20mg) PharmaQO 50
Tadalafil is a selective phosphodiesterase-5 inhibitor utilized in preclinical research investigating vascular smooth muscle signaling and PDE-5-mediated pathways in multiple tissue models. This PharmaQO-sourced 20 mg tablet formulation is optimized for comprehensive in-vitro and ex-vivo research examining cGMP dynamics, vascular endothelial function, and phosphodiesterase enzyme kinetics. The 50-tablet format supports systematic dose-response investigations in laboratory settings examining vascular physiology and endothelial function mechanisms.
Chemical Specifications:
- Chemical Name: (6R,12aR)-6-(1,3-benzodioxol-5-yl)-2,3,6,12,12a-pentahydro-2-methyl-pyrido[1′,2′:4,5]pyrimido[1,2-b][1,3]benzodiazepin-1(4H)-one
- Molecular Formula: C22H19N3O4
- Molecular Weight: 389.41 g/mol
- Compound Class: Phosphodiesterase-5 inhibitor
Tadalafil functions as a selective PDE-5 inhibitor with extended half-life characteristics, enabling research into sustained cGMP signaling in vascular tissue models. The compound supports investigations of vascular smooth muscle relaxation mechanisms and endothelial function in controlled preclinical protocols.
Research Applications:
- Examining phosphodiesterase-5 inhibition kinetics in enzyme assays
- Investigating cGMP signaling dynamics in vascular smooth muscle cell cultures
- Modeling sustained PDE-5 inhibition in vascular tissue preparations
- Characterizing dose-dependent vascular reactivity in isolated vessel studies
- Evaluating endothelial function and nitric oxide signaling pathways
Storage and Handling:
- Store at room temperature (20-25°C) in light-resistant containers
- Keep in original packaging with desiccant to control moisture
- Maintain stable storage temperature away from extreme heat
- Protect from humidity and direct sunlight exposure
Product Specifications:
- Purity: >98% HPLC
- Form: 20 mg each
- Appearance: Yellow to golden-yellow with film coating
- Quantity: 50 (1000 mg total)
FOR RESEARCH USE ONLY. Not intended for human consumption or clinical use. All products are sold strictly for laboratory, educational, and scientific research purposes.
Technical data
- Chemical Name
- (6R,12aR)-6-(1,3-benzodioxol-5-yl)-2,3,6,12,12a-pentahydro-2-methyl-pyrido[1',2':4,5]pyrimido[1,2-b][1,3]benzodiazepin-1(4H)-one
- Molecular Formula
- C22H19N3O4
- Molecular Weight
- 389.41 g/mol
Frequently asked questions
What is the molecular formula and weight of Tadalafil (Cialis 20mg) PharmaQO 50?
Molecular formula C22H19N3O4, molecular weight 389.41 g/mol.
How is Tadalafil (Cialis 20mg) PharmaQO 50 supplied?
In tablet form. The quantity and strength for this listing are given in the product name above.
Can Tadalafil (Cialis 20mg) PharmaQO 50 be used in humans or animals?
No. Every compound on this site is supplied for laboratory and research use only, and is not for human or veterinary use or consumption.
Research use only
Tadalafil (Cialis 20mg) PharmaQO 50 is supplied strictly as a research chemical for laboratory use. It is not for human or veterinary use or consumption, is not a drug, food or supplement, and is not approved by the U.S. Food and Drug Administration for any purpose.
Handle only in a controlled laboratory setting, by qualified personnel, in accordance with applicable law and good laboratory practice.
